Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
4562 ARTÍCULOS , VIENDO DEL 1471 AL 1485
Reversible, functional amyloids: towards an understanding of their regulation in yeast and humans
Cereghetti G, Saad S, Dechant R, Peter M.
Cell Cycle. 2018;17(13):1545-1558. doi: 10.1080/15384101.2018.1480220. Epub 2018 Aug 2.
Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson's Disease
McGee DJ, Lu XH, Disbrow EA.
J Parkinsons Dis. 2018;8(3):367-374. doi: 10.3233/JPD-181327.
Kufor-Rakeb Syndrome/PARK9: One Novel and One Possible Recurring Ashkenazi ATP13A2 Mutation
Inzelberg R, Estrada-Cuzcano A, Laitman Y, De Vriendt E, Friedman E, Jordanova A.
J Parkinsons Dis. 2018;8(3):399-403. doi: 10.3233/JPD-181360.
Functional Improvements in Parkinson's Disease Following a Randomized Trial of Yoga
Van Puymbroeck M, Walter AA, Hawkins BL, Sharp JL, Woschkolup K, Urrea-Mendoza E, Revilla F, Adams EV, Schmid AA.
Evid Based Complement Alternat Med. 2018 Jun 3;2018:8516351. doi: 10.1155/2018/8516351. eCollection 2018.
A new MAPT deletion in a case of speech apraxia leading to corticobasal syndrome
Mazzon G, Menichelli A, Fabretto A, Cattaruzza T, Manganotti P.
Neurocase. 2018 Jun;24(3):140-144. doi: 10.1080/13554794.2018.1492729. Epub 2018 Jul 3.
Is Targeting the Inflammasome a Way Forward for Neuroscience Drug Discovery?
Swanton T, Cook J, Beswick JA, Freeman S, Lawrence CB, Brough D.
SLAS Discov. 2018 Dec;23(10):991-1017. doi: 10.1177/2472555218786210. Epub 2018 Jul 3.
Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs
Paladino S, Conte A, Caggiano R, Pierantoni GM, Faraonio R.
Cell Physiol Biochem. 2018;47(5):1951-1976. doi: 10.1159/000491465. Epub 2018 Jul 3.
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Giguère N, Burke Nanni S, Trudeau LE.
Front Neurol. 2018 Jun 19;9:455. doi: 10.3389/fneur.2018.00455. eCollection 2018.
Weil R, Laplantine E, Curic S, Génin P.
Front Immunol. 2018 Jun 19;9:1243. doi: 10.3389/fimmu.2018.01243. eCollection 2018.
Chen JJ, Han Y, Tang J, Portillo I, Hauser RA, Dashtipour K.
Ann Pharmacother. 2018 Dec;52(12):1182-1194. doi: 10.1177/1060028018786954. Epub 2018 Jul 4.
Role of Curcumin in Regulation of TNF-α Mediated Brain Inflammatory Responses
Baj T, Seth R.
Recent Pat Inflamm Allergy Drug Discov. 2018;12(1):69-77. doi: 10.2174/1872213X12666180703163824.
Tailoring the deep brain stimulation indications in Parkinson's disease
Barbosa ER, Cury RG.
Arq Neuropsiquiatr. 2018 Jun;76(6):359-360. doi: 10.1590/0004-282X20180046.
Impulse control and related disorders in Parkinson's disease
Vargas AP, Cardoso FEC.
Arq Neuropsiquiatr. 2018 Jun;76(6):399-410. doi: 10.1590/0004-282X20180052.
Decisions about deep brain stimulation therapy in Parkinson's disease
Brandão P, Grippe TC, Modesto LC, Ferreira AGF, Silva FMD, Pereira FF, Lobo ME, Allam N, Freitas TDS, Munhoz RP.
Arq Neuropsiquiatr. 2018 Jun;76(6):411-420. doi: 10.1590/0004-282X20180048.
Fackrell R, Carroll CB, Grosset DG, Mohamed B, Reddy P, Parry M, Chaudhuri KR, Foltynie T.
Neurodegener Dis Manag. 2018 Oct;8(5):349-360. doi: 10.2217/nmt-2018-0020. Epub 2018 Jul 5.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.